[1]
“Adjuvant trastuzumab chemotherapy in early breast cancer: meta-analysis of randomised trials and cost-effectiveness analysis”, Swiss Med Wkly, vol. 149, no. 1920, p. w20082, May 2019, doi: 10.4414/smw.2019.20082.